The challenge to develop a safe, effective and low-cost universal malaria vaccine is being tackled by a DMTC collaboration with James Cook University’s Australian Institute of Tropical Health Medicine (AITHM), Townsville Hospital, Glycosyn and Pfizer Hospira. (more…)
A team of researchers from Swinburne are making a vital contribution to a DMTC-managed collaboration involving a national network of research and industry partners.
The DMTC project is focused on developing a detailed understanding of the functional performance of composite materials. The specific theme of work for the Swinburne researchers, led by Dr Nishar Hameed, is novel, hybrid graphene-based multi-scale composites that can deliver advances in sensing, electromagnetic and thermal signature control for applications in the defence domain. (more…)
A $3.9 million contract extension will help put cutting-edge capabilities into the hands of Australia’s service men and women, and build industrial supply chain capacity.
Minister for Defence Industry Melissa Price said the contract extension would help build a vibrant and competitive innovation sector within Australia’s defence industry. (more…)
A novel Q Fever vaccine is progressing to pre-clinical trials following a $1.87 million investment from the Department of Health into DMTC’s national Medical Countermeasures (MCM) Initiative. (more…)